+798.5%
MRNA vs GLXY
-38.8%
+837.3%
-35.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GLXY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -5.3% | +1.8% | -1.8% |
| 7D | -12.1% | +5.3% | -17.4% | -13.7% |
| 30D | -1.3% | -19.8% | +18.5% | +3.5% |
| 3M | +250.9% | -31.4% | +282.3% | +282.5% |
| 6M | +343.0% | -53.3% | +396.3% | +417.5% |
| YTD | +657.4% | -35.7% | +693.1% | +695.8% |
| 1Y | +794.9% | -47.2% | +842.1% | +869.7% |
| All | +798.5% | -38.8% | +837.3% | +830.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GLXY.
Daily Out/Under-Performance
Portfolio return minus GLXY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLXY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GLXY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling